The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1

Dipeptidyl Peptidase ◽

Endothelial Progenitor ◽

Dipeptidyl Peptidase 4 ◽

Circulating Endothelial Progenitor Cells ◽

Dipeptidyl Peptidase 4 Inhibitor

MK-0626, A Dipeptidyl Peptidase-4 Inhibitor, Improves Neovascularization by Increasing Both the Number of Circulating Endothelial Progenitor Cells and Endothelial Nitric Oxide Synthetase Expression

Current Medicinal Chemistry ◽

10.2174/09298673113206660273 ◽

2014 ◽

Vol 21 (17) ◽

pp. 2012-2022 ◽

Cited By ~ 22

Author(s):

Chun-Ming Shih ◽

Yung-Hsiang Chen ◽

Yi-Wen -Lin ◽

Nai-Wen Tsao ◽

Shinn-Chih Wu ◽

...

Keyword(s):

Nitric Oxide ◽

Progenitor Cells ◽

Dipeptidyl Peptidase ◽

Endothelial Progenitor ◽

Dipeptidyl Peptidase 4 ◽

Nitric Oxide Synthetase ◽

Circulating Endothelial Progenitor Cells ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Endothelial Nitric Oxide

Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells

British Journal of Pharmacology ◽

10.1111/j.1476-5381.2012.02102.x ◽

2012 ◽

Vol 167 (7) ◽

pp. 1506-1519 ◽

Cited By ~ 54

Author(s):

Chun-Yao Huang ◽

Chun-Ming Shih ◽

Nai-Wen Tsao ◽

Yi-Wen Lin ◽

Po-Hsun Huang ◽

...

Keyword(s):

Progenitor Cells ◽

Dipeptidyl Peptidase ◽

Endothelial Progenitor ◽

Dipeptidyl Peptidase 4 ◽

Circulating Endothelial Progenitor Cells ◽

Dipeptidyl Peptidase 4 Inhibitor

Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy in patients with type 2 diabetes mellitus

Acta Ophthalmologica ◽

10.1111/j.1755-3768.2015.0327 ◽

2015 ◽

Vol 93 ◽

pp. n/a-n/a

Author(s):

Z. Wu ◽

M. Ty ◽

F. Wang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Diabetic Retinopathy ◽

Progenitor Cells ◽

Endothelial Progenitor ◽

An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2016.06.008 ◽

2016 ◽

Vol 10 (4) ◽

pp. 205-212 ◽

Cited By ~ 5

Author(s):

Alexander E. Berezin ◽

Tatyana A Samura ◽

Alexander A. Kremzer ◽

Tatyana A Berezina ◽

Yulia V. Martovitskaya ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Progenitor Cells ◽

Endothelial Progenitor ◽

Impaired in vivo reendothelialization capacity of endothelial progenitor cells of patients with type-2 diabetes is restored by PPAR-gamma agonist rosiglitazone: Role of NAD(P)H oxygenase and nitric oxide

Vascular Pharmacology ◽

10.1016/j.vph.2006.08.116 ◽

2006 ◽

Vol 45 (3) ◽

pp. e27-e28 ◽

Cited By ~ 1

Author(s):

Sajoscha A. Sorrentino ◽

Ferdinand H. Bahlmann ◽

Christian Besler ◽

Maja Müller ◽

Danilo Fliser ◽

...

Keyword(s):

Nitric Oxide ◽

Type 2 Diabetes ◽

Progenitor Cells ◽

Ppar Gamma ◽

Endothelial Progenitor ◽

Ppar Gamma Agonist

Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2015.02.050 ◽

2015 ◽

Vol 458 (4) ◽

pp. 869-876 ◽

Cited By ~ 26

Author(s):

Qiong Yuan ◽

Chang-Ping Hu ◽

Zhi-Cheng Gong ◽

Yong-Ping Bai ◽

Si-Yu Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Progenitor Cells ◽

Asymmetric Dimethylarginine ◽

Dimethylarginine Dimethylaminohydrolase ◽

Endothelial Progenitor

Reconstituted HDL Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes

Arteriosclerosis Thrombosis and Vascular Biology ◽

10.1161/atvbaha.107.143875 ◽

2007 ◽

Vol 27 (8) ◽

pp. 1864-1865 ◽

Cited By ~ 45

Author(s):

O. van Oostrom ◽

M. Nieuwdorp ◽

P.E. Westerweel ◽

I.E. Hoefer ◽

R. Basser ◽

...

Keyword(s):

Type 2 Diabetes ◽

Progenitor Cells ◽

Endothelial Progenitor ◽

Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-020-07013-w ◽

2020 ◽

Author(s):

Feng-Yen Lin ◽

Chun-Min Shih ◽

Chun-Yao Huang ◽

Yi-Tin Tsai ◽

Shih-Hurng Loh ◽

...

Keyword(s):

Progenitor Cells ◽

Dipeptidyl Peptidase ◽

Endothelial Progenitor ◽

Allograft Vasculopathy ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Effect of Aliskiren on Circulating Endothelial Progenitor Cells and Vascular Function in Patients With Type 2 Diabetes and Essential Hypertension

American Journal of Hypertension ◽

10.1093/ajh/hpu119 ◽

2014 ◽

Vol 28 (1) ◽

pp. 22-29 ◽

Cited By ~ 22

Author(s):

A. E. Raptis ◽

K. P. Markakis ◽

M. C. Mazioti ◽

I. Ikonomidis ◽

E. P. Maratou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Essential Hypertension ◽

Progenitor Cells ◽

Vascular Function ◽

Endothelial Progenitor ◽

The decrement in circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.1159 ◽

2011 ◽

Vol 27 (2) ◽

pp. 185-194 ◽

Cited By ~ 10

Author(s):

Mingfang Li ◽

Jenny C. Y. Ho ◽

Kevin W. H. Lai ◽

Karen K. W. Au ◽

Aimin Xu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Progenitor Cells ◽

Endothelial Progenitor ◽